153 related articles for article (PubMed ID: 32952654)
1. Y-box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma.
Jeffords E; Freeman S; Cole B; Root K; Chekouo T; Melvin RG; Bemis L; Simmons GE
Oncol Lett; 2020 Nov; 20(5):165. PubMed ID: 32952654
[TBL] [Abstract][Full Text] [Related]
2. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
3. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
Song X; Liu J; Liu B; Piao C; Kong C; Li Z
Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor α promotes the synthesis of monounsaturated fatty acids in goat mammary epithelial cells via the control of stearoyl-coenzyme A desaturase 1 in an SREBP-1-dependent manner.
Yao DW; Luo J; He QY; Xu HF; Li J; Shi HB; Wang H; Chen Z; Loor JJ
J Dairy Sci; 2016 Aug; 99(8):6391-6402. PubMed ID: 27209141
[TBL] [Abstract][Full Text] [Related]
5. Positive feedback loop and synergistic effects between hypoxia-inducible factor-2α and stearoyl-CoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma.
Zhang Y; Wang H; Zhang J; Lv J; Huang Y
Cancer Sci; 2013 Apr; 104(4):416-22. PubMed ID: 23331615
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer.
Tracz-Gaszewska Z; Dobrzyn P
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31284458
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
8. Potential Links between YB-1 and Fatty Acid Synthesis in Clear Cell Renal Carcinoma.
McCauley C; Anang V; Cole B; Simmons GE
Med Res Arch; 2020 Oct; 8(10):. PubMed ID: 33778158
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
10. Stearoyl-CoA Desaturase 1 as a Therapeutic Biomarker: Focusing on Cancer Stem Cells.
Min JY; Kim DH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240297
[TBL] [Abstract][Full Text] [Related]
11. Relationship between stearoyl-CoA desaturase 1 gene expression, relative protein abundance, and its fatty acid products in bovine tissues.
Rezamand P; Watts JS; Yavah KM; Mosley EE; Ma L; Corl BA; McGuire MA
J Dairy Res; 2014 Aug; 81(3):333-9. PubMed ID: 24904960
[TBL] [Abstract][Full Text] [Related]
12. Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.
Iwai T; Kume S; Chin-Kanasaki M; Kuwagata S; Araki H; Takeda N; Sugaya T; Uzu T; Maegawa H; Araki SI
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834856
[TBL] [Abstract][Full Text] [Related]
13. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.
Raeisi M; Hassanbeigi L; Khalili F; Kharrati-Shishavan H; Yousefi M; Mehdizadeh A
Mol Biol Rep; 2022 Sep; 49(9):8871-8882. PubMed ID: 35906508
[TBL] [Abstract][Full Text] [Related]
14. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
15. Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action.
Zhang J; Kris-Etherton PM; Thompson JT; Hannon DB; Gillies PJ; Heuvel JP
J Nutr Biochem; 2012 Apr; 23(4):400-9. PubMed ID: 21658928
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol acyltransferase 1, stearoyl-CoA desaturase 1, and sterol regulatory element binding protein 1 gene polymorphisms and milk fatty acid composition in Italian Brown cattle.
Conte G; Mele M; Chessa S; Castiglioni B; Serra A; Pagnacco G; Secchiari P
J Dairy Sci; 2010 Feb; 93(2):753-63. PubMed ID: 20105547
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into stearoyl-CoA desaturase-1.
Ntambi JM; Miyazaki M
Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
[TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer.
Wang C; Shi M; Ji J; Cai Q; Zhao Q; Jiang J; Liu J; Zhang H; Zhu Z; Zhang J
Aging (Albany NY); 2020 Jul; 12(15):15374-15391. PubMed ID: 32726752
[TBL] [Abstract][Full Text] [Related]
19. p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1.
Rabow Z; Laubach K; Kong X; Shen T; Mohibi S; Zhang J; Fiehn O; Chen X
Cells; 2022 Aug; 11(16):. PubMed ID: 36010592
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
